Tumor stromal barriers to the success of adoptive T cell therapy
- PMID: 17646987
- PMCID: PMC11030862
- DOI: 10.1007/s00262-007-0356-6
Tumor stromal barriers to the success of adoptive T cell therapy
Comment on
-
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.Cancer Immunol Immunother. 2008 Feb;57(2):271-80. doi: 10.1007/s00262-007-0355-7. Epub 2007 Jul 24. Cancer Immunol Immunother. 2008. PMID: 17646988 Free PMC article. Clinical Trial.
References
-
- Yee C, et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA. 2002;99(25):16168–16173. doi: 10.1073/pnas.242600099. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
